GALLIVAC IB88 NEO
GALLIVAC IB88 NEO
Authorised
- Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Product identification
Medicine name:
GALLIVAC IB88 NEO
Active substance:
- Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Target species:
-
Chicken (broiler)
Route of administration:
-
Inhalation use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type 793/B, strain CR88121, Live4.00/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
Inhalation use
- Chicken (broiler)
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Italia S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- MINSAL
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
